Subscribe to Search results

Mr Justice Ognall wrote a letter to all parties, urging settlement.

Published on:

Decision of the High Court about disclosure and public interest immunity.

Published on:

Court of Appeal orders disclosure of most of the documents, and makes observations in passing about the nature of the claims.

Published on:

Settlement was proposed in the HIV Haemophilia Litigation by lawyers acting on behalf of the plaintiffs.

Published on:

William Waldegrave wrote to the Prime Minister recommending settlement in the HIV Haemophilia Litigation.

Published on:

Prime Minister announced settlement in HIV Haemophilia Litigation in Parliament.

Published on:

Settlement of claims was agreed in England and Wales. Agreement contained plaintiff waiver of future claims, including claims for hepatitis.

Published on:

Settlement terms in respect of Scottish claims were finalised, there is no waiver in respect of hepatitis.

Published on:

The Chiron Corporation in California announced the identification of non-A non-B (Hepatitis C) virus.

Published on:

The development of the anti-HCV ELISA test was announced.

Published on:

By this date it was agreed that a decision whether and when to implement a screening test for Hepatitis C would be made on a UK-wide basis.

Published on:

It was agreed at a meeting of the ACVSB to support the general introduction of the test for Hepatitis C if the FDA approved it and the pilot showed it to be "feasible and non-problematic".

Published on:

The FDA granted a permit for the Chiron/Ortho test (Hepatitis C test) to be exported for diagnostic use as well as research.

Published on:

The ACVSB decided that Hepatitis C testing should not be introduced in advance of a decision by the FDA.

Published on:

The ACVSB decided the introduction of routine Hepatitis C screening was not yet justified.

Published on:

The FDA approved the anti-HCV ELISA test and US blood banks commenced screening.

Published on:

The ACVSB approved Hepatitis C screening in principle but recommended there should be a pilot study to decide which test (Ortho or Abbott) was better.

Published on:

The ACVSB agreed Hepatitis C screening should be started as soon as practicable but no date was proposed.

Published on:

Minister approved routine screening for Hepatitis C.

Published on:

Dr Harold Gunson informed RTC directors that screening for anti-HCV would begin on 1 July 1991.

Published on: